标题
Advances and innovations in haemophilia treatment
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume 17, Issue 7, Pages 493-508
出版商
Springer Nature
发表日期
2018-06-08
DOI
10.1038/nrd.2018.70
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors-A retrospective analysis
- (2018) M. Carcao et al. HAEMOPHILIA
- Gene therapy comes of age
- (2018) Cynthia E. Dunbar et al. SCIENCE
- BAX 855, a PEGylated rFVIII product with prolonged half-life
- (2018) M. J. Bossard et al. Hamostaseologie
- First-line immune tolerance induction for children with severe haemophilia A: A protocol from the UK Haemophilia Centre Doctors' Organisation Inhibitor and Paediatric Working Parties
- (2017) P. Collins et al. HAEMOPHILIA
- Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial
- (2017) Céline Vandamme et al. HUMAN GENE THERAPY
- Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
- (2017) Lindsey A. George et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emicizumab Prophylaxis in Hemophilia A with Inhibitors
- (2017) Johannes Oldenburg et al. NEW ENGLAND JOURNAL OF MEDICINE
- AAV5–Factor VIII Gene Transfer in Severe Hemophilia A
- (2017) Savita Rangarajan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Factor VIIIa-mimetic cofactor activity of a bispecific antibody to factors IX/IXa and X/Xa, emicizumab, depends on its ability to bridge the antigens
- (2017) Keiko Esaki et al. THROMBOSIS AND HAEMOSTASIS
- Prophylactic efficacy of BeneFIX vs Alprolix in hemophilia B mice
- (2016) B. Cooley et al. BLOOD
- Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A
- (2016) S. W. Pipe et al. BLOOD
- Design and characterization of an APC-specific serpin for the treatment of hemophilia
- (2016) Stéphanie G. I. Polderdijk et al. BLOOD
- Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice
- (2016) Sriram Krishnamoorthy et al. CELLULAR IMMUNOLOGY
- Achievements, challenges and unmet needs for haemophilia patients with inhibitors
- (2016) Y. Dargaud et al. HAEMOPHILIA
- Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate®) in patients with severe haemophilia A
- (2016) R. Klamroth et al. HAEMOPHILIA
- Efficacy and safety of BAY 81-8973, a full-length recombinant factor VIII: results from the LEOPOLD I trial
- (2016) K. Saxena et al. HAEMOPHILIA
- Extension of in vivo half-life of biologically active molecules by XTEN protein polymers
- (2016) Vladimir N. Podust et al. JOURNAL OF CONTROLLED RELEASE
- Innovation in the pharmaceutical industry: New estimates of R&D costs
- (2016) Joseph A. DiMasi et al. JOURNAL OF HEALTH ECONOMICS
- PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs
- (2016) Peter L. Turecek et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits: a two-center study
- (2016) A. E. Bowyer et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Advances and challenges in hemophilic arthropathy
- (2016) Tine Wyseure et al. SEMINARS IN HEMATOLOGY
- Evaluation of Nonacog Beta Pegol Long-term Safety in the Immune-deficient Rowett Nude Rat (Crl:NIH-Foxn1rnu)
- (2016) Caroline E. Rasmussen et al. TOXICOLOGIC PATHOLOGY
- Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters
- (2015) William R. Strohl BIODRUGS
- A balance between TFPI and thrombin-mediated platelet activation is required for murine embryonic development
- (2015) P. E. R. Ellery et al. BLOOD
- Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A
- (2015) B. A. Konkle et al. BLOOD
- Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens
- (2015) J. Oldenburg BLOOD
- US experience with recombinant factor VIIa for surgery and other invasive procedures in acquired haemophilia: analysis from the Hemostasis and Thrombosis Research Society Registry
- (2015) A. D. Ma et al. HAEMOPHILIA
- Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy
- (2015) Randy J. Chandler et al. JOURNAL OF CLINICAL INVESTIGATION
- Spatiotemporal regulation of coagulation and platelet activation during the hemostatic responsein vivo
- (2015) L. Ivanciu et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial
- (2015) P. Chowdary et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia
- (2015) Alfica Sehgal et al. NATURE MEDICINE
- Liver-directed lentiviral gene therapy in a dog model of hemophilia B
- (2015) Alessio Cantore et al. Science Translational Medicine
- FcRn Rescues Recombinant Factor VIII Fc Fusion Protein from a VWF Independent FVIII Clearance Pathway in Mouse Hepatocytes
- (2015) Arjan van der Flier et al. PLoS One
- Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial
- (2014) P. W. Collins et al. BLOOD
- Increased cancer risk in patients with haemophilia A: a nationwide population-based 14-year study in Taiwan
- (2014) C.-J. Liu et al. HAEMOPHILIA
- Phase I study of BAY 94-9027, a PEGylated B-domain-deleted recombinant factor VIII with an extended half-life, in subjects with hemophilia A
- (2014) T. E. Coyle et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Comparative field study: impact of laboratory assay variability on the assessment of recombinant factor IX Fc fusion protein (rFIXFc) activity
- (2014) Yang Buyue et al. THROMBOSIS AND HAEMOSTASIS
- A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models
- (2013) H. R. Stennicke et al. BLOOD
- Platelet gene therapy corrects the hemophilic phenotype in immunocompromised hemophilia A mice transplanted with genetically manipulated human cord blood stem cells
- (2013) Q. Shi et al. BLOOD
- Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A
- (2013) J. Mahlangu et al. BLOOD
- Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics
- (2013) Timo Rath et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- Pharmacokinetics, efficacy and safety of BAX326, a novel recombinant factor IX: a prospective, controlled, multicentre phase I/III study in previously treated patients with severe (FIX level
- (2013) J. Windyga et al. HAEMOPHILIA
- Comparative field study evaluating the activity of recombinant factor VIII Fc fusion protein in plasma samples at clinical haemostasis laboratories
- (2013) J. M. Sommer et al. HAEMOPHILIA
- Enhancing the pharmacokinetic properties of recombinant factor VIII: first-in-human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A
- (2013) A. Tiede et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B
- (2013) Jerry S. Powell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity
- (2013) Zenjiro Sampei et al. PLoS One
- Comparability studies of new 3rd generation recombinant human factor VIII GreenGene F after improvement of formulation and viral inactivation/removal process
- (2012) Sang Hoon Paik et al. BIOLOGICALS
- Prolonged activity of a recombinant factor VIII-Fc fusion protein in hemophilia A mice and dogs
- (2012) J. A. Dumont et al. BLOOD
- Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients
- (2012) E. Santagostino et al. BLOOD
- Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model
- (2012) I. Hilden et al. BLOOD
- Pharmacokinetic properties of IB1001, an investigational recombinant factor IX, in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysis
- (2012) U. Martinowitz et al. HAEMOPHILIA
- Guidelines for the management of hemophilia
- (2012) A. Srivastava et al. HAEMOPHILIA
- Biochemical and functional characterization of a recombinant monomeric factor VIII-Fc fusion protein
- (2012) R. T. PETERS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model
- (2012) Takehisa Kitazawa et al. NATURE MEDICINE
- Functional characteristics of the novel, human-derived recombinant FVIII protein product, human-cl rhFVIII
- (2012) Helena Sandberg et al. THROMBOSIS RESEARCH
- Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide
- (2011) H. Ostergaard et al. BLOOD
- Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia B
- (2011) C. Negrier et al. BLOOD
- The principal results of the International Immune Tolerance Study: a randomized dose comparison
- (2011) C. R. M. Hay et al. BLOOD
- Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®) - an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia A
- (2011) U. MARTINOWITZ et al. HAEMOPHILIA
- International comparative field study of N8 evaluating factor VIII assay performance
- (2011) D. VIUFF et al. HAEMOPHILIA
- Clinical severity of haemophilia A: does the classification of the 1950s still stand?
- (2011) I. E. M. Den UIJL et al. HAEMOPHILIA
- Improving reperfusion therapy for acute ischaemic stroke
- (2011) J. L. SAVER JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
- (2011) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prolonged activity of factor IX as a monomeric Fc fusion protein
- (2010) R. T. Peters et al. BLOOD
- Rational design of a fully active, long-acting PEGylated factor VIII for hemophilia A treatment
- (2010) B. Mei et al. BLOOD
- Clinical evaluation of moroctocog alfa (AF-CC), a new generation of B-domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full-length recombinant factor VIII
- (2009) M. RECHT et al. HAEMOPHILIA
- The cell-based model of coagulation
- (2009) Stephanie A. Smith JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE
- X-Linked Thrombophilia with a Mutant Factor IX (Factor IX Padua)
- (2009) Paolo Simioni et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started